Grand Tour Cycle from Brussels to Barcelona to Raise Awareness of Diabetes and to Highlight the Benefits of mHealth

The GSMA announced the mHealth Grand Tour cycle ride, which will start in Brussels on the 5th September and finish in Barcelona on the 18th September 2013. The Grand Tour will bring together diabetes patient communities and the mobile and healthcare industries to raise awareness of diabetes and to promote healthy and active living, and showcase how mobile technology can help address the challenge of managing the condition and reduce the cost of care. In conjunction with this announcement, the GSMA also launched its mDiabetes campaign, which will explore how mHealth can support and transform diabetes treatment.

"In Europe, more than 55 million people, or 8.5 per cent of the population, live with diabetes and it is recognised as the number one cause of death across the region," said Michael O'Hara, Chief Marketing Officer, GSMA. "The mHealth Grand Tour will help build visibility of this public health crisis, as well as demonstrate how innovative mobile-based solutions can help people address diabetes and related conditions and liberate them to lead active lifestyles. It will also be a tremendously exciting experience and we are encouraging as many teams as possible to take part."

For the mHealth Grand Tour, the GSMA will partner with the International Diabetes Federation European Region (IDF Europe), an umbrella organisation that promotes diabetes care, prevention and research, and advocates for the rights of the 55 million people living with the condition in Europe. "Through this Grand Tour we want to raise awareness for diabetes, which affects an increasing number of citizens across Europe and worldwide. We also want to show how essential healthy lifestyles and physical activity are in diabetes prevention and management," commented João Nabais, President of IDF Europe.

The 14-day Grand Tour will cover 2,100 kilometres over four stages, with more than 22,000 metres of climbs, incorporating breath-taking scenery and quiet country roads. In the spirit of Europe's Grand Tours, the route will take riders through places of interest across Belgium, France and Spain, affording participants the opportunity to enjoy the sights and local culture.

Jose Perdomo, Director of eHealth at Telefónica Digital, a member of the GSMA mHealth Leadership Board, said: "We know from our own trials that mobile technology can transform quality of life for patients with conditions such as diabetes, and, at the same time, foster efficiency for healthcare providers and payers. We welcome initiatives such as the GSMA’s mHealth Grand Tour, which will help demonstrate the capabilities of how mobile technology can manage chronic conditions in real-life circumstances."

Diabetes UK, the UK's leading Diabetes charity, with a growing community of 300,000 people nationwide, is a key supporter of the mHealth Grand Tour and has confirmed it will be entering a team. The charity recently won the Third Sector Excellence Award for Use of Digital Media for its Diabetes UK Tracker mobile app, which is designed to take the daily chore out of logging levels such as blood glucose, carbohydrates and calories.

"New technology and mobile-based solutions, such as the Diabetes UK Tracker app, can play a vital part in empowering someone with diabetes to be able to manage their condition in the way that suits them. This is why Diabetes UK is supporting the mHealth Grand Tour," said Svetlana Kirov, Diabetes UK Deputy Director of Fundraising. "We welcome keen cyclists who are up for this challenge to join the Diabetes UK team to help us raise funds to continue our important work. The money raised through the Grand Tour will help us to make life better for the 3.7 million people in the UK with diabetes and the 7 million people at high risk."

"Anyone can participate in the mHealth Grand Tour by joining a charity team, a mobile or healthcare industry team, or by entering their own company team," commented O'Hara. "This is not a race - the teams are there for mutual support and to help foster a collegiate atmosphere on the ride. Riders can travel at their own pace and we expect the teams will mix it up on the road, which will be part of the fun and the experience."

To register a team, please visit:
http://www.mhealthtour.com

About the GSMA
The GSMA represents the interests of mobile operators worldwide. Spanning more than 220 countries, the GSMA unites nearly 800 of the world's mobile operators with more than 230 companies in the broader mobile ecosystem, including handset makers, software companies, equipment providers and Internet companies, as well as organisations in industry sectors such as financial services, healthcare, media, transport and utilities. The GSMA also produces industry-leading events such as the Mobile World Congress and Mobile Asia Expo.

Most Popular Now

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...